pentetic acid has been researched along with Paraganglioma in 8 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Paraganglioma: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Contrast enhancement with gadopentetate dimeglumine has been advocated to increase the efficacy of MR imaging for paragangliomas of the head and neck." | 5.07 | MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement. ( Bloem, JL; Dillon, EH; Falke, TH; Pauwels, EK; Prins, HJ; van den Berg, R; van der Mey, AG; van Gils, AP, 1994) |
| "Our case occurred in association with neurofibromatosis type 1 and in the absence of an identified primary tumor." | 1.39 | MIBG superscan of metastatic paraganglioma occurring with neurofibromatosis type 1. ( Barron, BJ; Harrison, CE, 2013) |
| "Of the 60 evaluable patients, 51 had carcinoid tumours, 3 gastrinomas, 2 glucagonomas, 1 insulinoma and 3 paragangliomas." | 1.33 | Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours. ( Arnold, R; Bauhofer, A; Béhé, MP; Behr, TM; Gotthardt, M; Grass, J; Kalinowski, M; Oyen, WJ; Rinke, A; Schipper, ML, 2006) |
| "In patients with carcinoids, a combination of somatostatin receptor scintigraphy, chest radiograph and ultrasound of the upper abdomen had a high sensitivity for tumor localization, and detected lesions in patients in whom no tumor was found with conventional imaging, justifying the greater cost." | 1.29 | Cost-effectiveness analysis of somatostatin receptor scintigraphy. ( Habbema, JD; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrison, CE | 1 |
| Barron, BJ | 1 |
| Bomanji, JB | 1 |
| Papathanasiou, ND | 1 |
| Gotthardt, M | 1 |
| Béhé, MP | 1 |
| Grass, J | 1 |
| Bauhofer, A | 1 |
| Rinke, A | 1 |
| Schipper, ML | 1 |
| Kalinowski, M | 1 |
| Arnold, R | 1 |
| Oyen, WJ | 1 |
| Behr, TM | 1 |
| Perri, M | 1 |
| Erba, P | 1 |
| Volterrani, D | 1 |
| Lazzeri, E | 1 |
| Boni, G | 1 |
| Grosso, M | 1 |
| Mariani, G | 1 |
| Tenenbaum, F | 1 |
| Lumbroso, J | 1 |
| Schlumberger, M | 1 |
| Mure, A | 1 |
| Plouin, PF | 1 |
| Caillou, B | 1 |
| Parmentier, C | 1 |
| van Gils, AP | 1 |
| van den Berg, R | 1 |
| Falke, TH | 1 |
| Bloem, JL | 1 |
| Prins, HJ | 1 |
| Dillon, EH | 1 |
| van der Mey, AG | 1 |
| Pauwels, EK | 1 |
| Kwekkeboom, DJ | 1 |
| Lamberts, SW | 1 |
| Habbema, JD | 1 |
| Krenning, EP | 1 |
| Díez, L | 1 |
| Rioja, M | 1 |
| Cordero, J | 1 |
| Caballero, C | 1 |
| Crespo, A | 1 |
1 review available for pentetic acid and Paraganglioma
| Article | Year |
|---|---|
¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Iodine Radioisotopes; Neu | 2012 |
2 trials available for pentetic acid and Paraganglioma
| Article | Year |
|---|---|
Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Humans; Male; Middle Aged | 2008 |
MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
Topics: Adult; Aged; Contrast Media; Drug Combinations; Gadolinium DTPA; Head and Neck Neoplasms; Humans; Ma | 1994 |
5 other studies available for pentetic acid and Paraganglioma
| Article | Year |
|---|---|
MIBG superscan of metastatic paraganglioma occurring with neurofibromatosis type 1.
Topics: 3-Iodobenzylguanidine; Female; Humans; Middle Aged; Neurofibromatosis 1; Octreotide; Paraganglioma; | 2013 |
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Glucagonoma; Humans; Indium Radioisot | 2006 |
Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Female; Ganglioneuroblastoma; Humans; I | 1995 |
Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Cost-Benefit Analysis; Costs and Cost | 1996 |
[Congenital cyanotic heart disease and peripheral neurogenic tumor].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Chronic Disease; Dextrocardia; Epilepsy, Ton | 1999 |